News about Market

Genethon Partners with AskBio on Pompe Gene Therapy

The licensing deal enables AskBio to advance the clinical development of Genethon’s investigational gene therapy for Pompe disease through an industry partnership.

Market | 15/01/2026 | By News Bureau |  170

Amneal Unveils New Brand to Expand Access to Medicines

The refreshed brand features a new visual identity and “Signature” logo that reflects trust in healthcare, patient impact, and Amneal’s focus on expanding access to medicines across complex therapeutic areas.

Market | 15/01/2026 | By News Bureau |  239

Dr Reddy's Launches First-to-Market Olopatadine Ophthalmic Solution in US

With the US launch of its first-to-market OTC Olopatadine 0.7 percent eye drops, Dr Reddy’s expands access to allergy relief for itchy eyes caused by pollen and other common allergens.

Market | 15/01/2026 | By News Bureau |  156

Bayer to Enter Molecular Imaging, Acquires Pan-Amyloid Radiotracers from Attralus

By acquiring AT-01 and AT-05 from Attralus, Bayer strengthens its molecular imaging and cardiovascular precision medicine portfolio, targeting earlier and more accurate diagnosis of amyloidosis.

Market | 14/01/2026 | By News Bureau |  226

Thermo Fisher and NVIDIA Partner to Advance AI-Driven Scientific Instrumentation

Under the partnership, Thermo Fisher Scientific and NVIDIA will connect laboratory instruments and data systems with advanced AI capabilities to streamline operations and accelerate scientific research.

Market | 14/01/2026 | By News Bureau |  160

EQT Life Sciences Exits Vivasure Medical Following Sale to Haemonetics

EQT Life Sciences, formerly known as LSP, one of Europe’s largest life sciences investors, has announced that its LSP Health Economics Fund has exited Vivasure Medical Limited, a Galway-based medical device company, following its acquisition by Haemonetics Corporation, a global medical technology company.

Market | 13/01/2026 | By Darshana |  220

West Pharmaceutical Services to Sell SmartDose 3.5mL On-Body Delivery System to AbbVie for USD 112.5 Million

West Pharmaceutical Services has entered a definitive agreement to divest the manufacturing and supply rights of its SmartDose 3.5mL On-Body Delivery System to AbbVie, as part of a strategic portfolio review, with the transaction expected to close in mid-2026.

Market | 13/01/2026 | By News Bureau |  361

Merck Explores USD 28-32 Billion Buyout of Oncology Biotech Revolution Medicines

Merck & Co. is in discussions to acquire U.S.-based oncology biotech Revolution Medicines in a deal that could value the company between USD 28 billion and USD 32 billion, according to people familiar with the matter.

Market | 11/01/2026 | By Darshana |  318

MediLink, Roche Sign Global Licensing Deal for YL201 ADC Therapy

Agreement includes USD 570 million upfront and milestones to advance B7H3-targeting solid tumor cancer treatment worldwide.

Market | 09/01/2026 | By News Bureau |  465

ABS Bio Buys Cureline, Enhancing Biospecimen Access and Execution

The add-on acquisition of Cureline by ABS Bio, a 3 Boomerang portfolio company, expands ABS Bio’s capabilities, geographic reach and client base while strengthening its end-to-end biospecimen services.

Market | 08/01/2026 | By News Bureau |  172